LFA
RMD icon

LGT Financial Advisors’s ResMed RMD Stock Holding History

LGT Financial Advisors’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-4
Closed -$1.03K – 595
2025
Q2 		$1.03K Buy
+4
New +$954 ﹤0.01% 392
2025
Q1 		– Sell
-50
Closed -$11.4K – 636
2024
Q4 		$11.4K Hold
50
– – 0.03% 415
2024
Q3 		$12.2K Hold
50
– – 0.03% 375
2024
Q2 		$9.57K Hold
50
– – 0.02% 480
2024
Q1 		$9.9K Hold
50
– – 0.01% 501
2023
Q4 		$8.6K Hold
50
– – 0.01% 513
2023
Q3 		$7.39K Buy
+50
New +$9.04K 0.01% 539

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

LGT Financial Advisors's RMD Position: Q3 2025 in Review

LGT Financial Advisors sold out of ResMed (RMD) in Q3 2025, closing a stake of 4 shares — an estimated $1.03K sold.

LGT Financial Advisors first reported a position in RMD in Q3 2023 and held it in 7 quarters. The position peaked at $12.2K in Q3 2024. 950 funds tracked by Wall St. Rank hold RMD as of Q3 2025.

  • LGT Financial Advisors reported no remaining ResMed position as of Q3 2025 after selling out during the quarter.
  • LGT Financial Advisors sold 4 ResMed shares in Q3 2025, an estimated $1.03K.
  • LGT Financial Advisors first reported a position in ResMed in Q3 2023 and held it in 7 quarters.
  • LGT Financial Advisors's ResMed position peaked at $12.2K in Q3 2024.
  • 950 funds tracked by Wall St. Rank held ResMed as of Q3 2025.

Based on LGT Financial Advisors's 13F filing for Q3 2025, filed 17 Nov 2025.